Die dominante Rolle der Lipide bei der multifaktoriell bestimmten Arteriosklerose ist mittlerweile unumstritten. Die Angabe der Hauptveröffentlichungen und die Nennung des Projektleiters vereinfacht die Beschaffung von Detailinformationen.

Cholesterin — der “jüngste” Risikofaktor!.- All-Union Cooperative Study of Multifactorial Prevention of Ischaemic Heart Disease.- Anti-Coronary Club Program.- Association of Serum Lipids and Obesity with Cardiovascular Mortality.- The Atherosclerotic Risk in Communities (ARIC) Study.- Basel-Studie.- The Bogalusa Heart Study.- The British Regional Heart Study.- Cardiovascular Disease Risk Factor Study in Oppland.- Cholesterin-Programm Bielefeld 1988.- Cholesterol Lowering Atherosclerosis Study (CLAS).- Cholesterol-Lowering Effects of Psyllium Hydrophilic Mucilloid.- Colestipol in Hypercholesterolemic Patients.- The Collaborative Family Study.- Controlled Trial of Soya-Bean Oil in Myocardial Infarction.- The Coronary Drug Project.- Coronary Prevention Evaluation Program (CPEP).- Deutsche Herz-Kreislauf-Präventionsstudie (DHP).- Diet and Its Relation to Coronary Heart Disease.- Donolo-Tel Aviv Prospective Coronary Artery Disease Study.- Edinburgh-Stockholm Study.- European Collaborative Trial of Multifactorial Prevention of Coronary Heart Disease.- Evans County Study.- The Finnish Mental Hospital Study.- The Framingham Offspring Study.- HDL in the Framingham Study.- Gesundenuntersuchung der Stadt Wien.- The Göttingen Risk, Incidence, and Prevalence Study (GRIPS).- HDL in Four Prospective American Studies.- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle Aged Men with Dyslipidemia.- Hokuriku FH-CHD Study.- The Honolulu Heart Program.- Hyperlipoproteinemia in Danish Newborns.- Israeli Ischaemic Heart Disease Study.- Kölner Studie zum kardiovaskulären Risikoprofil bei Jugendlichen.- The Kuopio Ischaemic Heart Disease Risk Factor Study.- The Leiden Intervention Trial.- The Lipid Research Clinic Coronary Primary Prevention Study (LRC-CPPT).-The Lipid Research Clinics Program Prevalence Study.- Lipids and Angiographically Defined Coronary Artery Disease in Japanese Patients.- The Lovastatin Study Group III.- The Minnesota Heart Health Program (MHHP).- Multifactorial Primary Prevention of Cardiovascular Disease in Middle-aged Men.- The Mulifactor Primary Prevention Trial in Göteborg.- Multiple Risk Factor Intervention Trial (MRFIT).- North Karelia Project.- The Oslo Diet-Heart Study.- The Oslo Study.- Poland and US Colaborative Study on Cardiovascular Epidemiology.- Prevalence of Hyperlipoproteinaemias in a Random Sample of Men and in Patients with Ischaemic Heart Disease.- The Princeton School District Study.- Prospektive Cardiovaskuläre Münster-Studie (PROCAM).- The Puerto Rico Heart Health Program.- Renfrew and Paisley Survey.- San Antonio Heart Study.- The Scottish Heart Health (SSHS) and Scottish MONICA-Studies.- The Second National Health and Nutrition Examination Survey (NHANES II).- Serum Cholesterol in Early Childhood.- Serum HDL Cholesterol in a High Coronary Risk Population in Eastern Finland.- Serum Lipid Response to Dietary Cholesterol.- Serum Lipoproteins and Coronary Artery Disease.- The Speedwell Study (Pilot Study).- The Stockholm Prospective Study.- The Tecumseh Study.- Ten-year Experience of Modified-Fat Diets on Younger Men with Coronary Heart-Disease.- The Tromso Heart Study.- The Western Electric Study.- WHO Cooperative Trial on Primary Prevention of Ischemic Heart Disease with Clofibrate to Lower Serum Cholesterol.- The Yugoslavia Cardiovascular Disease Study.- Personenregister.- Sachwortregister.

GPSR Compliance The European Union's (EU) General Product Safety Regulation (GPSR) is a set of rules that requires consumer products to be safe and our obligations to ensure this. If you have any concerns about our products you can contact us on ProductSafety@springernature.com. In case Publisher is established outside the EU, the EU authorized representative is: Springer Nature Customer Service Center GmbH Europaplatz 3 69115 Heidelberg, Germany ProductSafety@springernature.com